In this study, we employed multi-modal molecular and clinical analyses of diverse, independent datasets (TCGA, IvyGap, CPTAC, GLASS, and GBM single-cell transcriptomics) to develop a new classification system for IDH wild-type GBM patients. Here, IDH1 is linked to glioblastoma.